Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes but we are heading toward the end of August, about 1 month and a half after the forecasted time.
How many times have you heard of the word "hopefully" in this MB? I would say quite too often...
How about some more dilution?
"Please note that following on from advice received from the company this appraisal has been rescheduled to align with latest regulatory expectations"
Blaming those who shorted the stock for current price would mean that anything else went on right. You tell us.
Doesn't sound convincing at all.
As usual, an interesting rational point of view.
So, when is the article going to be published?
Nice reading on the MB lately. It doesn't surprise me that many people who used to act as longs and long time supporters, aren't writing on the MB anymore.
By the way, does anyone care to hint of what is the co.'s cash position right now?
Your theory is interesting, but IMO unproven. But statistics is always welcomed in this MB, there are quite a few statisticians in here, too.
I wonder if you had the same thoughts by reading the last 8k with recent cash raises...
Mesenchymal subgroup does not seem small, does it?
I already pointed out the most credibile source, go read it yourself and add the recente raises.
Too bad that the most recent 10-K lists:
"As of April 14, 2017 the registrant had 186,061,822 shares of common stock outstanding".
Then you can start counting what happened next.
I believe someone in the MB is confusing it with fully diluted numbers...
That's amazing how the co.'s reports have a different number than yours as for oustanding shares. You might want to go check them and then come back to discuss them.
It would surely be nice, but I strongly doubt it could hit that price today if a substantial news doesn't come out.
One thing is for sure: the price movement is indicative of a strong accumulation in a market where sells have gone. This could be either someone taking a large position in anticipation of results, or shorts covering in anticipation of results. Whatever the reason, it will be very beneficial as many warrant holders will IMO start to convert their securities and thus the co. might not need to raise additional money in the very near future to run operations.
Right, my same thought.
Even if the results would equal Optune, it should find a way for some sort of approval.
IMO you confirmed what I meant.
For the record it's good to know (and IMO less so for the trial) that some long time MB longs are now finally admitting that they believe primary endpoint might fail. IMO next step, in connecting the dots, would be to finally aknowledge that the problem with the stock price was not shorts or naked shorts at all (an argument that some longs in the MB have tried to put in place for such a long time with no minimal proof), but IMO more evidently the possibility that some investors sold their position simply because they had the feeling the trial could fail, pure and simple. Blaiming unknown forces, IMO sometimes doesn't help to see what might be happening 1 foot ahead.
Obviously, since many MB longs have been wrong with their buy signals all the way for such a long time, most investors I believe will now hope that those concerned about a potential primary endpoint fail, are wrong this time, too, and that the trial will somehow show objective efficacy even in the primary endpoint.
Though I am not convinced at all it yields to 16%, for the rest of the post I tend to agree with you.
After so many positive posts, stating that what ultimately matters is a stat sig secondary endpoint looks pretty negative to me.
Sounds fair.
Is it the same FDA that was supposed to stop another study earlier for efficacy? Oh yeah, I get the idea, lol.
Congrats, because it's not always that easy to pinpoint a PPS like that. You have a future.
Whenever I read a MB I don't put it as to who to believe, but rather as to who has been right, with arguements, to predict a stock trend.
0.5 is not the average strike price, and a simple math exercise would show that if all the convertibile would be exercised in full the shares issued would be much more than 12M.
5,175M per their last PR (5M principal plus 175K interest).
I agree. Kudos to RK.
RK, sorry but I believe you are twisting it in here, again (obviously in good faith, I believe, but still different from original posts IMO). Anyhow, if you now believe, as I do, that they will unblind right when 233 event have been reached, then it means we now agree on that. That's pure and simple and there's no need to go further in this discussion, I believe.
By the way, I never said anything that you are now claiming I said, like this:
RK, once again, this was what you originally wrote down (see previous posts):
But you are mixing up the co.'s will (which I believe will be to unblind as soon as 233 OS events are reached), with DMC or other outside timing matters. Going back to the main point, I do not believe the co. is willing to wait for more than 233 OS events before unblind, thus I don't agree with your view. Anyhow, in a couple of weeks we will eventually find out.
I don't agree on this. I believe they will unblind at 233. They already reached PFS about 6 months ago and I believe they want to move this forward as soon as possible. Therefore I believe they will call for 233 OS within a couple of weeks and announce path to unblind and gather results.